Literature DB >> 10604243

Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.

H Klüter1, S Bubel, H Kirchner, D Wilhelm.   

Abstract

BACKGROUND: Nonhemolytic transfusion reactions (NHTRs) frequently occur after platelet transfusions. White cell (WBC)-derived inflammatory cytokines can cause these reactions, but they are rarely found in WBC-poor platelet preparations. Transfusion reactions were investigated with regard to the residual WBC content in the stored platelet concentrate in two consecutive study periods. STUDY DESIGN AND METHODS: In the first study period, platelet concentrates were WBC-reduced by bedside filtration. In the second period, all platelet concentrates were filtered before storage. Recipients who experienced transfusion reactions were examined with regard to their main clinical symptoms during and after transfusion. In the supernatant of the involved platelet concentrates, concentrations of interleukin (IL)-1beta, IL-6, IL-8, tumor necrosis factor (TNF)alpha, macrophage inflammatory protein 1alpha, and RANTES were analyzed.
RESULTS: The incidence of transfusion reactions remained steady when the transfusion regimen was changed from bedside filtration to prestorage WBC filtration (1.63% and 1.56%; p = 0.84). In both periods, NHTRs were predominantly of allergic origin. Inflammatory mediators IL-1beta, IL-6, IL-8, and TNFalpha were detectable in only a minority of platelet components involved in NHTRs. Platelet concentrates involved in allergic reactions contained high concentrations of RANTES (668 +/- 223 ng/mL).
CONCLUSIONS: Prestorage WBC filtration did not reduce the incidence of these reactions, and inflammatory cytokines were of minor relevance. The proinflammatory platelet-derived chemokine RANTES, which accumulates even in WBC-reduced platelet concentrates, was associated with allergic transfusion reactions. Platelet-derived mediators may be a key to understanding NHTRs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604243     DOI: 10.1046/j.1537-2995.1999.39111179.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  15 in total

1.  Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.

Authors:  Eva María Plaza; María Luisa Lozano; Isabel Sánchez Guiu; José Manuel Egea; Vicente Vicente; Laura Collantes De Terán; José Rivera
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

2.  Evaluation of White Blood Cell- and Platelet-Derived Cytokine Accumulation in MIRASOL-PRT-Treated Platelets.

Authors:  Susanne M Picker; Alexander Steisel; Birgit S Gathof
Journal:  Transfus Med Hemother       Date:  2009-03-04       Impact factor: 3.747

3.  Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.

Authors:  William J Savage; Jessica H Savage; Aaron A R Tobian; Chris Thoburn; Robert G Hamilton; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2011-08-29       Impact factor: 3.157

4.  Reactions Induced by Platelet Transfusions.

Authors:  Volker Kiefel
Journal:  Transfus Med Hemother       Date:  2008-09-16       Impact factor: 3.747

5.  Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.

Authors:  Nahreen Tynngård; Agneta Wikman; Michael Uhlin; Per Sandgren
Journal:  Blood Transfus       Date:  2019-07-04       Impact factor: 3.443

Review 6.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

Review 7.  Current methods for the reduction of blood-borne pathogens: a comprehensive literature review.

Authors:  Susanne M Picker
Journal:  Blood Transfus       Date:  2013-03-14       Impact factor: 3.443

8.  Treatment of buffy coat platelets in platelet additive solution with the mirasol(®) pathogen reduction technology system.

Authors:  Azucena Castrillo; Marcia Cardoso; Lindsay Rouse
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

9.  Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates.

Authors:  Iyonna Woods; Abdul Tawab-Amiri; Karen Byrne; Marianna Sabatino; David F Stroncek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

10.  Microarray kit analysis of cytokines in blood product units and segments.

Authors:  Richard B Weiskopf; Rebecca Yau; Rosa Sanchez; Clifford Lowell; Pearl Toy
Journal:  Transfusion       Date:  2009-06-22       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.